AAAAAA

   
Results: 1-3 |
Results: 3

Authors: ADAMI S PASSERI M ORTOLANI S BROGGINI M CARRATELLI L CARUSO I GANDOLINI G GNESSI L LAURENZI M LOMBARDI A NORBIATO G PRYORTILLOTSON S REDA C ROMANINI L SUBRIZI D WEI L YATES AJ
Citation: S. Adami et al., EFFECTS OF ORAL ALENDRONATE AND INTRANASAL SALMON-CALCITONIN ON BONE MASS AND BIOCHEMICAL MARKERS OF BONE TURNOVER IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS, Bone, 17(4), 1995, pp. 383-390

Authors: PORRECA E REALE M DIFEBBO C BARBACANE RC CASTELLANI ML CIPOLLONE F CARRATELLI L CONTI P CUCCURULLO F
Citation: E. Porreca et al., EFFECT OF MK-571, A SELECTIVE LEUKOTRIENE D-4 RECEPTOR ANTAGONIST, ONVASCULAR SMOOTH-MUSCLE CELL-PROLIFERATION AND INTERLEUKIN-1 RELEASE, International journal of immunopathology and pharmacology, 7(1), 1994, pp. 57-64

Authors: ADAMI S BARONI MC BROGGINI M CARRATELLI L CARUSO I GNESSI L LAURENZI M LOMBARDI A NORBIATO G ORTOLANI S RICERCA E ROMANINI L SUBRIZI S WEINBERG J YATES AJ
Citation: S. Adami et al., TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS WITH CONTINUOUS DAILY ORAL ALENDRONATE IN COMPARISON WITH EITHER PLACEBO OR INTRANASAL SALMON-CALCITONIN, Osteoporosis international, 3, 1993, pp. 190000021-190000027
Risultati: 1-3 |